Publicaciones en colaboración con investigadores/as de Hospital del Mar (18)

2024

  1. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

    British Journal of Surgery, Vol. 111, Núm. 3

2023

  1. Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study

    Thrombosis Journal, Vol. 21, Núm. 1

  2. Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204

  3. Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

  2. Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure

    ESC Heart Failure, Vol. 9, Núm. 1, pp. 656-666

  3. Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome

    Journal of Clinical Medicine, Vol. 11, Núm. 6

  4. Familial component of early-onset colorectal cancer: opportunity for prevention

    The British journal of surgery, Vol. 109, Núm. 12, pp. 1319-1325

2021

  1. Cohort profile: The Spanish Early-onset Colorectal Cancer (SECOC) cohort: A multicentre cohort study on the molecular basis of colorectal cancer among young individuals in Spain

    BMJ Open, Vol. 11, Núm. 12

  2. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

    Gut, Vol. 70, Núm. 2, pp. 319-329

2020

  1. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 29, Núm. 5, pp. 1009-1018

  2. Renal denervation for the treatment of resistant hypertension in Spain. The Flex-Spyral Registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 615-622

  3. The development of chronic diuretic resistance can be predicted during a heartfailure hospitalization. Results from the REDIHF registry

    PLoS ONE, Vol. 15, Núm. 10 October

2019

  1. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches

    International Journal of Cancer, Vol. 144, Núm. 7, pp. 1540-1549

2018

  1. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives

    International Journal of Epidemiology, Vol. 47, Núm. 2, pp. 473-483

2017

  1. Reduced risk of pancreatic cancer associated with asthma and nasal allergies

    Gut, Vol. 66, Núm. 2, pp. 314-322

2008

  1. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: A Spanish multicenter study of 300 patients

    American Journal of Gastroenterology, Vol. 103, Núm. 1, pp. 71-76

2003

  1. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: A double-blind RCT

    Hepatology, Vol. 37, Núm. 6, pp. 1260-1266